Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026)

Cresco Labs (CRLBF) posted Income from Non-Controlling Interests of -$3.9 million for Q1 2026, down 189.64% on a QoQ basis from -$1.4 million in Q4 2025, and down 391.52% year-over-year from $1.4 million in Q1 2025.

Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Cresco Labs' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

  • Quarterly Income from Non-Controlling Interests fell 391.52% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 177.69% YoY) and the FY2025 annual result came in at -$4.6 million, down 133.24% from the prior year.
  • Income from Non-Controlling Interests was -$3.9 million for Q1 2026 at Cresco Labs, down from -$1.4 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $6.5 million in Q3 2022 and bottomed at -$19.3 million in Q4 2022.
  • A 5-year average of -$162058.8 and a median of $2.2 million in 2023 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests sank 783.66% — and 2024, when it surged 278.19%.
  • Cresco Labs' Income from Non-Controlling Interests stood at -$19.3 million in 2022, then surged by 111.58% to $2.2 million in 2023, then jumped by 115.45% to $4.8 million in 2024, then sank by 128.29% to -$1.4 million in 2025, then tumbled by 189.64% to -$3.9 million in 2026.
  • Business Quant data shows CRLBF's Income from Non-Controlling Interests at -$3.9 million in Q1 2026, -$1.4 million in Q4 2025, and -$4.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 395,346.10
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Cresco Labs 245.85 Mn 182.28 Mn 75.45 Mn -3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.94 Mn
Dec 31, 2025 -1.36 Mn
Sep 30, 2025 -4.91 Mn
Jun 30, 2025 2.44 Mn
Mar 31, 2025 -802,000.00
Dec 31, 2024 4.81 Mn
Sep 30, 2024 2.85 Mn
Jun 30, 2024 3.15 Mn
Mar 31, 2024 3.14 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 -6.93 Mn
Mar 31, 2023 -1.76 Mn
Dec 31, 2022 -19.29 Mn
Sep 30, 2022 6.54 Mn
Jun 30, 2022 5.25 Mn
Mar 31, 2022 3.71 Mn
Dec 31, 2021 2.82 Mn
Sep 30, 2021 7.19 Mn
Jun 30, 2021 7.48 Mn